SGLT2 inhibitors in HFrEF, a meta-analytical approach.

Open Access

SGLT2 inhibitors in HFrEF, a meta-analytical approach.

Session: New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients

Topic: Treatment

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

103 presentations

4 followers

4 more presentations in this session

Introduction.

Speaker: Professor J. Butler (Dallas, US)

Access

Video

EMPEROR-REDUCED Trial: main results.

Speaker: Doctor M. Packer (Dallas, US)

Access

Video

Panel discussion

Speaker: Professor G. Filippatos (Athens, GR) Professor J. Butler (Dallas, US) Professor M. Packer (Dallas, US) Professor S. Anker (Berlin, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access

Video

Conclusion.

Speaker: Professor M. Packer (Dallas, US)

Access

Video

Access the full session

New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients

Speakers: Professor F. Zannad, Professor J. Butler, Doctor M. Packer, Professor G. Filippatos, Professor J. Butler...

Access

Video

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources